Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongliang He

Showing results (61-70 of 95) with videos related to

Pageof 10
Sort By:
Frontiers in Pharmacology|January 4, 2021
Synergetic Effect of rHDL and LXR Agonist on Reduction of Atherosclerosis in MiceEmily E Morin, Yanhong Guo, Hongliang He, et al.
Nature Communications|July 13, 2024
Elucidating the catalytic mechanism of Prussian blue nanozymes with self-increasing catalytic activityKaizheng Feng, Zhenzhen Wang, Shi Wang, et al.
RSC Advances|August 11, 2015
Synthesis of surface nano-molecularly imprinted polymers for sensitive baicalin detection from biological samplesXiaoli Gu, Hongliang He, Chong-Zhi Wang, et al.
Biosensors & Bioelectronics|April 11, 2025
Water-stable perovskite/metallic nanocomposites-based SERS aptasensor for detection of neuron-specific enolaseJiayi Miao, Yifan Liu, Yi Xiao, et al.
Frontiers in Pharmacology|September 15, 2022
Development of activated endothelial targeted high-density lipoprotein nanoparticlesMinzhi Yu, Kristen Hong, Reheman Adili, et al.
Frontiers in Microbiology|November 7, 2022
Corrigendum: Identification of novel therapeutic candidates against SARS-CoV-2 infections: An application of RNA sequencing toward mRNA based nanotherapeuticsZunera Khalid, Ma Huan, Muhammad Sohail Raza, et al.
Frontiers in Microbiology|August 19, 2022
Identification of Novel Therapeutic Candidates Against SARS-CoV-2 Infections: An Application of RNA Sequencing Toward mRNA Based NanotherapeuticsZunera Khalid, Ma Huan, Muhammad Sohail Raza, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 2, 2026
Engineering ROS-responsive size-transformable nanoassemblies to reprogram plaque microenvironment and activate autophagy for atherosclerosis therapyYanyan Wang, Kaishun Qi, Youyou Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 16, 2025
Impact of CD4+ T cell and TCR repertoires on SARS-CoV-2-Specific antibody responses in PLWH following COVID-19 vaccinationChengchao Ding, Qianqian Chen, Yu Shi, et al.
Journal of Medical Virology|August 20, 2022
Evaluation of humoral immune responses induced by different SARS-CoV-2 spike trimers from wild-type and emerging variants with individual, sequential, and combinational delivered strategiesChengchao Ding, Shuangshuang Ni, Xiangyu Zhang, et al.
Pageof 10

Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
Frontiers in Pharmacology|January 4, 2021
Synergetic Effect of rHDL and LXR Agonist on Reduction of Atherosclerosis in MiceEmily E Morin, Yanhong Guo, Hongliang He, et al.
Nature Communications|July 13, 2024
Elucidating the catalytic mechanism of Prussian blue nanozymes with self-increasing catalytic activityKaizheng Feng, Zhenzhen Wang, Shi Wang, et al.
RSC Advances|August 11, 2015
Synthesis of surface nano-molecularly imprinted polymers for sensitive baicalin detection from biological samplesXiaoli Gu, Hongliang He, Chong-Zhi Wang, et al.
Biosensors & Bioelectronics|April 11, 2025
Water-stable perovskite/metallic nanocomposites-based SERS aptasensor for detection of neuron-specific enolaseJiayi Miao, Yifan Liu, Yi Xiao, et al.
Frontiers in Pharmacology|September 15, 2022
Development of activated endothelial targeted high-density lipoprotein nanoparticlesMinzhi Yu, Kristen Hong, Reheman Adili, et al.
Frontiers in Microbiology|November 7, 2022
Corrigendum: Identification of novel therapeutic candidates against SARS-CoV-2 infections: An application of RNA sequencing toward mRNA based nanotherapeuticsZunera Khalid, Ma Huan, Muhammad Sohail Raza, et al.
Frontiers in Microbiology|August 19, 2022
Identification of Novel Therapeutic Candidates Against SARS-CoV-2 Infections: An Application of RNA Sequencing Toward mRNA Based NanotherapeuticsZunera Khalid, Ma Huan, Muhammad Sohail Raza, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 2, 2026
Engineering ROS-responsive size-transformable nanoassemblies to reprogram plaque microenvironment and activate autophagy for atherosclerosis therapyYanyan Wang, Kaishun Qi, Youyou Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 16, 2025
Impact of CD4+ T cell and TCR repertoires on SARS-CoV-2-Specific antibody responses in PLWH following COVID-19 vaccinationChengchao Ding, Qianqian Chen, Yu Shi, et al.
Journal of Medical Virology|August 20, 2022
Evaluation of humoral immune responses induced by different SARS-CoV-2 spike trimers from wild-type and emerging variants with individual, sequential, and combinational delivered strategiesChengchao Ding, Shuangshuang Ni, Xiangyu Zhang, et al.
Pageof 10